Cancer News and Research

Latest Cancer News and Research

Trial of low-dose Isotretinoin for prevention of second primary tumors in head and neck cancer patients

Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.

13 Apr 2006

Soy intake may be associated with a small reduction in the risk of breast cancer

However, because of limitations and inconsistencies in the studies examined within the meta-analysis, the authors caution that evidence is not sufficient to recommend soy as a means of preventing breast cancer.

13 Apr 2006

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

The findings come three years after a related WHI study found that a different type of hormone therapy - which combined estrogen and progestin - did result in a higher risk of breast cancer among postmenopausal women.

13 Apr 2006

Advances in chemotherapy significantly reduce risk of disease recurrence in breast cancer patients

Recent advances in chemotherapy have significantly reduced the risk of disease recurrence and death in breast cancer patients whose tumors are not hormone sensitive, according to a study by researchers at Dana-Farber Cancer Institute and 10 other institutions.

13 Apr 2006

Active ingredient in soy may explain why Asians have lower rates of obesity and cancer

A single nutrient found in soy products elicits changes in gene behavior that permanently reduce an embryo's risk of becoming obese later in life, according to an animal study at Duke University Medical Center.

13 Apr 2006

Environmental scientists identify new culprits in the cancer equation

In the granite-rich region of Western North Carolina, taking a daily shower could pose a risk of developing lung cancer. So could working from home every day. That's because granite emits a carcinogenic gas, radon.

13 Apr 2006

Regulatory focus and efficacy of health messages

You know slathering on the SPF helps prevent skin cancer. So why don't you do it?

13 Apr 2006

A drink or two a day may be associated with better cognitive function in women

"Women who had up to two drinks a day scored about 20 percent higher on the Mini Mental State Exam (MMSE) than women who didn't drink at all or who consumed less than one drink a week," said Clinton Wright, M.D., M.S., lead author of the study.

13 Apr 2006

Cardiocerebral resuscitation improves survival of patients with out-of-hospital cardiac arrest

Survival rates following the most common form of cardiac arrest increased three-fold when emergency medical personnel used a new form of CPR developed at The University of Arizona Sarver Heart Center.

13 Apr 2006

New risks identified after early breast cancer

A new study of women with early stage, localized breast cancer identifies new patterns and risk factors for invasive disease that may influence how patients are treated.

13 Apr 2006

Prostate cancer risk linked to high cholesterol

Italian Researchers say they have found what they believe to be the first direct link between high cholesterol levels and prostate cancer.

12 Apr 2006

Tough times ahead for NHS despite record investment

British Prime Minister Tony Blair yesterday met with the chief executives of sixteen Primary Care Trusts to discuss the financial crisis dogging the National Health Service (NHS).

12 Apr 2006

Review examines the management of radiotherapy induced rectourethal fistula

Rectourethral fistulas (RUF) are a challenging problem observed by urological and colorectal surgeons.

11 Apr 2006

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.

11 Apr 2006

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

A research team led by the University of Cincinnati's Bibiana Bielekova, MD, report new insights into the role of the MS drug daclizumab (Zenapax) in the Proceedings of the National Academy of Sciences.

11 Apr 2006

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

The patient of a periodontist in private practice in New Orleans developed osteonecrosis of the jaw (ONJ), a condition that can cause severe, often irreversible and debilitating damage to the jaw, following periodontal surgical therapy.

11 Apr 2006

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

A study led by researchers from the Howard Hughes Medical Institute has found that dasatinib provides significant benefit in chronic myeloid leukemia (CML) patients resistant to Gleevec. (imatinib), according to a study presented during the 97th Annual Meeting of the American Association for Cancer Research.

11 Apr 2006

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters, says a team of researchers in the Journal of the American Medical Association.

11 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Researchers identify the role of a protein in hemoglobin gene silencing

Virginia Commonwealth University Massey Cancer Center researchers have identified the role of a protein in hemoglobin gene silencing that may one day be a potential target for the treatment of genetic blood disorders like sickle-cell anemia and beta-thalassemia on the molecular level.

11 Apr 2006

Cancer News and Research

Latest Cancer News and Research

Trial of low-dose Isotretinoin for prevention of second primary tumors in head and neck cancer patients

Soy intake may be associated with a small reduction in the risk of breast cancer

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

Advances in chemotherapy significantly reduce risk of disease recurrence in breast cancer patients

Active ingredient in soy may explain why Asians have lower rates of obesity and cancer

Environmental scientists identify new culprits in the cancer equation

Regulatory focus and efficacy of health messages

A drink or two a day may be associated with better cognitive function in women

Cardiocerebral resuscitation improves survival of patients with out-of-hospital cardiac arrest

New risks identified after early breast cancer

Prostate cancer risk linked to high cholesterol

Tough times ahead for NHS despite record investment

Review examines the management of radiotherapy induced rectourethal fistula

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

Researchers identify the role of a protein in hemoglobin gene silencing

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in